Research and development in the pharmaceutical industry is incredibly expensive and time-consuming, therefore DRK is constantly seeking ways of cutting costs and speeding up the process, a catered approach to provide you with the best of results.
By in-licensing high-quality products that our state-of-the-art R&D works on, our clients have the window to avail reduced expenditure on R&D, and also the potential to offset the limitations of their existing product pipelines, otherwise subdued by budgetary restraints in recent years.
Through our out-licensing capabilities, DRK also provides pharmaceutical companies with the opportunity to enter into markets where they have no existing presence or present distinct opportunities for growth.
We at DRK are set to provide you with the best business model, suiting your product requirements and company initiatives.
Our OL services include dynamic product packages, such as,
OL with Supply
OL with Tech pack
Regulatory approvals
